New prospects for the rational design of antivirals

Nature Medicine

Volumn 15, Issue 11, 2009, Pages 1253-1254

  Nistal Villán, Estanislao ^a   García Sastre, Adolfo ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMANTADINE; AMINO ACID; ANTIVIRUS AGENT; CELL PROTEIN; OSELTAMIVIR; RIMANTADINE; RNA DIRECTED RNA POLYMERASE; SMALL INTERFERING RNA; VIRUS RNA; ZANAMIVIR;

ANTIVIRAL THERAPY; CRYSTAL STRUCTURE; CRYSTALLOGRAPHY; DRUG DESIGN; ENZYME ACTIVITY; HIGH THROUGHPUT SCREENING; HOST CELL; HUMAN; INFLUENZA; INFLUENZA VIRUS; INFLUENZA VIRUS A H1N1; MESSENGER RNA SYNTHESIS; NONHUMAN; PANDEMIC; PREVALENCE; PRIORITY JOURNAL; PROBABILITY; PROTEIN PROTEIN INTERACTION; PROTEIN RNA BINDING; RNA REPLICATION; RNA TRANSCRIPTION; SHORT SURVEY; VIRUS INFECTION; VIRUS REPLICATION; VIRUS STRAIN; VIRUS VIRULENCE;

ANTIVIRAL AGENTS; DRUG DESIGN; HUMANS; INFLUENZA, HUMAN; VIRAL PROTEINS;

EID: 70449127983     PISSN: 10788956     EISSN: 1546170X     Source Type: Journal    
DOI: 10.1038/nm1109-1253     Document Type: Short Survey

References (15)

1. Thompson, W.W. et al. J. Am. Med. Assoc. 289, 179-186 (2003).
2. Johnson, N.P. & Mueller, J. Bull. Hist. Med. 76, 105-115 (2002).
3. Garten, R.J. et al. Science 325, 197-201 (2009).
4. Itoh, Y. et al. Nature 460, 1021-1025 (2009).
5. Hancock, K. et al. N. Engl. J. Med. published online, doi:10.1056/NEJMoa0906453 (10 September 2009).
6. Moscona, A. N. Engl. J. Med. 360, 953-956 (2009).
7. Beigel, J. & Bray, M. Antiviral Res. 78, 91-102 (2008).
8. Obayashi, E. et al. Nature 454, 1127-1131 (2008).
9. He, X. et al. Nature 454, 1123-1126 (2008).
10. Sugiyama, K. et al. EMBO J. 28, 1803-1811 (2009).
11. Guilligay, D. et al. Nat. Struct. Mol. Biol. 15, 500-506 (2008).
12. Tarendeau, F. et al. Nat. Struct. Mol. Biol. 14, 229-233 (2007).
13. Yuan, P. et al. Nature 458, 909-913 (2009).
14. Dias, A. et al. Nature 458, 914-918 (2009).
15. Zhao, C. et al. J. Virol. 83, 9024-9030 (2009).